近日，京信通信推出的16*16度立体方波赋形天线解决方案成功解决了"苏超"场馆的通信挑战，该方案 不仅解决了赛事拥塞难题，更为未来智慧场馆建设提供了可复制的标杆案例。目前，立体方波赋形天线 解决方案已批量应用于南京奥体中心、南京青奥中心、苏州奥体中心、连云港体育中心等多个赛事主场 的网络覆盖。 京信通信(02342)涨超5%，截至发稿，涨7.49%，报2.87港元，成交额1.15亿港元。 东莞证券研报指出，2025年通信行业处于技术迭代与政策红利叠加期，AI、量子通信、低空经济等新 质生产力方向将持续释放增长动能，基站、光缆线路、数据中心等通信设施建设有望持续推进，带来新 的器件、设备与服务运营需求。 公开资料显示，京信通信是全球领先的无线通信与信息解决方案及服务提供商，为全球运营商及政企客 户提供业界领先的全场景无线网络及智慧行业解决方案和服务。 ...

智通财经APP获悉，京信通信(02342)涨超5%，截至发稿，涨7.49%，报2.87港元，成交额1.15亿港元。 公开资料显示，京信通信是全球领先的无线通信与信息解决方案及服务提供商，为全球运营商及政企客 户提供业界领先的全场景无线网络及智慧行业解决方案和服务。 近日，京信通信推出的16*16度立体方波赋形天线解决方案成功解决了"苏超"场馆的通信挑战，该方案 不仅解决了赛事拥塞难题，更为未来智慧场馆建设提供了可复制的标杆案例。目前，立体方波赋形天线 解决方案已批量应用于南京奥体中心、南京青奥中心、苏州奥体中心、连云港体育中心等多个赛事主场 的网络覆盖。 东莞证券研报指出，2025年通信行业处于技术迭代与政策红利叠加期，AI、量子通信、低空经济等新 质生产力方向将持续释放增长动能，基站、光缆线路、数据中心等通信设施建设有望持续推进，带来新 的器件、设备与服务运营需求。 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年8月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 京信通信系統控股有限公司 呈交日期: 2025年9月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02342 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 5,000,000,000 | HKD | | 0.1 HKD | | 500,000,000 | | 增加 / 減少 (-) | | | 0 | | | HKD | | 0 | | 本月底結存 | | | 5,000,000,000 | HKD | | 0.1 HKD | | 500,000,000 | 本月底法定/註冊股本總額： HKD 500, ...

Group 1 - The core viewpoint of the article highlights that Jingxin Communication (02342) experienced a stock price increase of over 3%, reaching HKD 2.53 with a trading volume of HKD 58.44 million [1] - The company reported a revenue of HKD 2.199 billion for the six months ending June 30, 2025, representing a year-on-year decrease of 6.16% [1] - The profit attributable to the owners of the parent company was HKD 61.78 million, a significant improvement from a loss of HKD 158 million in the same period last year [1] Group 2 - The basic earnings per share were reported at HKD 0.0209, and the company proposed an interim dividend of HKD 0.006 per share [1] - The decline in revenue is attributed to a slowdown in capital project construction plans by global telecom operators, as well as the company's products and services being in a transitional phase of upgrades [1]

Core Viewpoint - The company, 京信通信, reported a revenue decline but achieved a profit turnaround, indicating potential resilience despite industry challenges [1] Financial Performance - The company reported a revenue of 2.199 billion HKD for the six months ending June 30, 2025, representing a year-on-year decrease of 6.16% [1] - The profit attributable to the parent company was 61.78 million HKD, a significant improvement from a loss of 158 million HKD in the same period last year [1] - Basic earnings per share were 0.209 HKD, and the company proposed an interim dividend of 0.006 HKD per share [1] Industry Context - The revenue decline is attributed to a slowdown in capital project construction plans by global telecom operators [1] - The company is undergoing a transitional phase with its products and business, indicating a potential upgrade cycle [1]

COMBA TELECOM SYSTEMS HOLDINGS LIMITED 京信通信系統控股有限公司（「本公司」，連同其附屬公司，統稱「本集 團」）董事會（「董事會」）成員載列如下 : 執行董事 霍東齡先生（主席） 張躍軍先生（副主席） 霍欣茹女士（總裁） 張飛虎先生（首席財務官） 葉卡女士（首席營銷官） 非執行董事 易磊先生 京 信 通 信 系 統 控 股 有 限 公 司 （於開曼群島註冊成立之有限公司） （香港股份代號：2342） （新加坡股份代號：STC） 董事名單與其角色和職能 王洛琳女士 （主席） 獨立非執行董事 伍綺琴女士 王洛琳女士 張智強先生 1 董事會設立四個委員會。各董事會成員在這些委員會中所擔任的職位載列如下 : 審核委員會 伍綺琴女士 （主席） 王洛琳女士 張智強先生 提名委員會 伍綺琴女士 張智強先生 薪酬委員會 張智強先生 （主席） 伍綺琴女士 王洛琳女士 執行委員會 （附註） 霍欣茹女士 （主席） 張飛虎先生 附註： 四名高級管理人員，即孫善球先生、李宇雯女士、向煒先生及李學鋒先生，亦 為執行委員會之成員。 香港，二零二五年八月二十日 2 ...

Major Events - CSPC Pharmaceutical Group (01093) received clinical trial approval for Dupilumab injection in China [1] - Rongchang Biopharmaceutical (09995) was granted breakthrough therapy designation for RC148 for non-small cell lung cancer by the National Medical Products Administration [1] - China Biologic Products (01177) included LM-302 "CLDN18.2 ADC" in the breakthrough therapy program [1] - Sunshine Oilsands (02012) plans to acquire 51% stake in Noble Technology Limited for HKD 50.91945 million [1] - Galenica Pharmaceutical-B (01672) plans to issue shares at a discount of approximately 9.9%, raising HKD 468 million [1] Financial Performance - Xiaomi Group-W (01810) reported record high revenue and profit for Q2, with attributable profit of HKD 11.904 billion, up 133.51% year-on-year [1] - Pop Mart (09992) announced a mid-term profit of HKD 4.574 billion, a year-on-year increase of 396.5% [1] - Fuyao Glass (03606) reported a half-year net profit of approximately HKD 4.805 billion, up 37.33% year-on-year [1] - China Resources Beer (00291) announced a mid-term profit of HKD 5.789 billion, an increase of 23.04% year-on-year [1] - Kunlun Energy (00135) reported a mid-term profit of HKD 3.161 billion, down 4.36% year-on-year, with a dividend of HKD 0.166 per share [1] - WuXi Biologics (02269) reported a mid-term profit of approximately HKD 2.339 billion, up 56% year-on-year [1] - Sunny Optical Technology (02382) announced a mid-term profit of HKD 1.646 billion, an increase of 52.56% year-on-year [1] - Yixin Group (02858) reported an adjusted net profit of HKD 648 million, up 28% year-on-year [1] - Kangchen Pharmaceutical (01681) reported a mid-term profit of HKD 498 million, up 24.6% year-on-year, maintaining market leadership with its flagship product [1] - Ping An Good Doctor (01833) reported a mid-term profit of HKD 134 million, a year-on-year increase of 136.84% [1] - China Communication Services (02342) reported a mid-term profit of HKD 61.781 million, returning to profitability [1] - XPeng Motors-W (09868) achieved record levels in core business and financial metrics for Q2, with a net loss of HKD 480 million, narrowing by 62.8% year-on-year [1] - Guochuang Tongqiao (02190) reported a mid-term profit of HKD 121 million, up 76% year-on-year [1] - Yanda Pharmaceutical (00512) reported record revenue of HKD 6.107 billion [1] - Jinli Permanent Magnet (06680) reported a mid-term profit of approximately HKD 305 million, up 154.81% year-on-year [1] - Zhaogang Group-W (06676) issued a profit warning, expecting a mid-term profit of approximately HKD 140 million to HKD 180 million, returning to profitability [1] - Longyuan Power (00916) reported a mid-term profit of HKD 3.519 billion, down 14.4% year-on-year [1] - Yancoal Australia (03668) reported a mid-term profit of AUD 16.3 million, down 61.19% year-on-year [1] - SF Holding (06936) reported total revenue of HKD 24.847 billion for July in logistics, supply chain, and international business, up 9.95% year-on-year [1] - Chow Sang Sang (00116) expects a mid-term profit from continuing operations of approximately HKD 900 million to HKD 920 million [1]

Core Viewpoint - The company reported a revenue of HKD 2.199 billion for the six months ending June 30, 2025, representing a year-on-year decrease of 6.16% [1] - The profit attributable to the owners of the parent company was HKD 61.78 million, a significant recovery from a loss of HKD 158 million in the same period last year [1] - The basic earnings per share were HKD 0.0209, and the company proposed an interim dividend of HKD 0.006 per share [1] Revenue Performance - The decline in revenue is attributed to a slowdown in capital project construction plans by global telecom operators and the company's products and services being in a transitional phase of upgrades [1] Future Outlook - The company anticipates both opportunities and challenges ahead, focusing on enhancing organizational efficiency and strengthening independent research and innovation capabilities [1] - The company aims to maintain product innovation and competitiveness while seizing new market opportunities and addressing customer needs to provide stable, high-quality, and cost-effective products and services to global operators and industry clients [1]

Group 1 - The company announced the appointment of Ms. Yekaterina as the Executive Director and Chief Marketing Officer, effective from August 20, 2025 [1]

Group 1 - The core point of the article is the appointment of Ms. Yekar as the Executive Director and Chief Marketing Officer of the company, effective from August 20, 2025 [1]